What are the progesterone-induced changes of the outcome and the serum markers of injury, oxidant activity and inflammation in diffuse axonal injury patients?

International Immunopharmacology

Volumn 32, Issue , 2016, Pages 103-110

  Mofid, Behshad ^a   Soltani, Zahra ^b   Khaksari, Mohammad ^c   Shahrokhi, Nader ^d   Nakhaee, Nouzar ^c   Karamouzian, Saeed ^a   Ahmadinejad, Mehdi ^a   Maiel, Masoud ^a   Khazaeli, Payam ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diffuse axonal injury; Interleukin 1 ; Interleukin 6; Oxidant activity; Progesterone; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; PROGESTERONE; PROTEIN S100B; TRANSFORMING GROWTH FACTOR BETA1; ANTIOXIDANT; BIOLOGICAL MARKER; CYTOKINE; NEUROPROTECTIVE AGENT; S100B PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIFFUSE AXONAL INJURY; FOLLOW UP; FUNCTIONAL INDEPENDENCE MEASURE; GLASGOW OUTCOME SCALE; HUMAN; LUNG EMBOLISM; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; THROMBOEMBOLISM; BLOOD; INFLAMMATION;

ADULT; ANTIOXIDANTS; BIOMARKERS; CYTOKINES; DIFFUSE AXONAL INJURY; HUMANS; INFLAMMATION; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; PROGESTERONE; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; SINGLE-BLIND METHOD;

EID: 84956766820     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2016.01.015     Document Type: Article

References (73)

1. D.H. Smith, D.F. Meaney, and W.H. Shull Diffuse axonal injury in head trauma J. Head Trauma Rehabil. 18 2003 307 316
2. H.M. Bramlett, and W.D. Dietrich Progressive damage after brain and spinal cord injury: pathomechanisms and treatment strategies Prog. Brain Res. 161 2007 125 141
3. C. Woiciechowsky, B. Schöning, J. Cobanov, and et al. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients J. Trauma Acute Care Surg. 52 2002 339 345
4. K.R. Swartz, F. Liu, D. Sewell, and et al. Interleukin-6 promotes post-traumatic healing in the central nervous system Brain Res. 896 2001 86 95
5. D.J. Loane, and A.I. Faden Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies Trends Pharmacol. Sci. 31 2010 596 604
6. J. Wei, and X. G-m The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects Acta Pharmacol. Sin. 34 2013 1485 1490
7. D.G. Stein A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury? Horm. Behav. 63 2013 291 300
8. D.G. Stein, and S.W. Hoffman Estrogen and progesterone as neuroprotective agents in the treatment of acute brain injuries Dev. Neurorehabil. 6 2003 13 22
9. M. Shakeri, M.R. Boustani, N. Pak, and et al. Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma Clin. Neurol. Neurosurg. 115 2013 2019 2022
10. D.W. Wright, A.L. Kellermann, V.S. Hertzberg, and et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury Ann. Emerg. Med. 49 2007 391 402 (e392)
11. G. Xiao, J. Wei, W. Yan, and et al. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial Crit. Care 12 2008 R61
12. B.E. Skolnick, A.I. Maas, R.K. Narayan, and et al. A clinical trial of progesterone for severe traumatic brain injury N. Engl. J. Med. 371 2014 2467 2476
13. D.W. Wright, S.D. Yeatts, R. Silbergleit, and et al. Very early administration of progesterone for acute traumatic brain injury N. Engl. J. Med. 371 2014 2457 2466
14. I. Dimopoulou, S. Korfias, U. Dafni, and et al. Protein S-100b serum levels in trauma-induced brain death Neurology 60 2003 947 951
15. P.F. Stahel, M.C. Morganti-Kossmann, D. Perez, and et al. Intrathecal levels of complement-derived soluble membrane attack complex (sC5b-9) correlate with blood-brain barrier dysfunction in patients with traumatic brain injury J. Neurotrauma 18 2001 773 781
16. L.E. Pelinka, A. Kroepfl, M. Leixnering, and et al. GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome J. Neurotrauma 21 2004 1553 1561
17. U.E. Pleines, M.C. Morganti-Kossmann, M. Rancan, and et al. S-100 β reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury J. Neurotrauma 18 2001 491 498
18. R. Donato, G. Sorci, F. Riuzzi, and et al. S100B's double life: intracellular regulator and extracellular signal Biochim. Biophys. Acta Mol. Cell Res. 1793 2009 1008 1022
19. R. A., CG, and V. Seifert Serum markers of brain damage and outcome prediction in patients after severe head injury Br. J. Neurosurg. 13 1999 56 59
20. K. Nylén, M. Öst, L.Z. Csajbok, and et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury Acta Neurochir. 150 2008 221 227
21. T. Rainey, M. Lesko, R. Sacho, and et al. Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24 h) time-point Resuscitation 80 2009 341 345
22. K. Mertsch, I. Blasig, and T. Grune 4-Hydroxynonenal impairs the permeability of an in vitro rat blood-brain barrier Neurosci. Lett. 314 2001 135 138
23. K.A. Hanafy, and M.H. Selim Antioxidant strategies in neurocritical care Neurotherapeutics 9 2012 44 55
24. P.B. Pun, J. Lu, and S. Moochhala Involvement of ROS in BBB dysfunction Free Radic. Res. 43 2009 348 364
25. L. Hillered, P.M. Vespa, and D.A. Hovda Translational neurochemical research in acute human brain injury: the current status and potential future for cerebral microdialysis J. Neurotrauma 22 2005 3 41
26. X. Ji, W. Liu, K. Xie, and et al. Beneficial effects of hydrogen gas in a rat model of traumatic brain injury via reducing oxidative stress Brain Res. 1354 2010 196 205
27. S.A. Baldwin, I. Fugaccia, D.R. Brown, and et al. Blood-brain barrier breach following cortical contusion in the rat J. Neurosurg. 85 1996 476 481
28. J. Cai, S. Cao, J. Chen, and et al. Progesterone alleviates acute brain injury via reducing apoptosis and oxidative stress in a rat experimental subarachnoid hemorrhage model Neurosci. Lett. 600 2015 238 243
29. R.L. Roof, S.W. Hoffman, and D.G. Stein Progesterone protects against lipid peroxidation following traumatic brain injury in rats Mol. Chem. Neuropathol. 31 1997 1 11
30. M. Schumacher, R. Guennoun, D.G. Stein, and A.F. De Nicola Progesterone: therapeutic opportunities for neuroprotection and myelin repair Pharmacol. Ther. 116 2007 77 106
31. N. Shahrokhi, M.K. Haddad, S. Joukar, and et al. Neuroprotective antioxidant effect of sex steroid hormones in traumatic brain injury Pak. J. Pharm. Sci. 25 2012 219 225
32. M. Djebaili, S. Hoffman, and D. Stein Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex Neuroscience 123 2004 349 359
33. E.H. Pettus, D.W. Wright, D.G. Stein, and S.W. Hoffman Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury Brain Res. 1049 2005 112 119
34. J.W. VanLandingham, M. Cekic, S. Cutler, and et al. Neurosteroids reduce inflammation after TBI through CD55 induction Neurosci. Lett. 425 2007 94 98
35. N. Shahrokhi, M. Khaksari, Z. Soltani, and et al. Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury Can. J. Physiol. Pharmacol. 88 2010 414 421
36. M. Khaksari, Z. Soltani, N. Shahrokhi, and et al. The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury Can. J. Physiol. Pharmacol. 89 2011 31 40
37. A.R. Sarkaki, M. Khaksari Haddad, Z. Soltani, and et al. Time- and dose-dependent neuroprotective effects of sex steroid hormones on inflammatory cytokines after a traumatic brain injury J. Neurotrauma 30 2013 47 54
38. S.J. Sandler, A.A. Figaji, and P.D. Adelson Clinical applications of biomarkers in pediatric traumatic brain injury Childs Nerv. Syst. 26 2010 205 213
39. D. Moher, S. Hopewell, K.F. Schulz, and et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials J. Clin. Epidemiol. 63 2010 e1 e37
40. S. Li, J. Marks, P. Sanati, and et al. 2: In vivo evolution of microvascular inflammation after traumatic brain injury: an intravital microscopy study Crit. Care Med. 39 2011 1
41. R. Bullock, R. Chesnut, G. Clifton, and et al. Guidelines for the management of severe head injury Eur. J. Emerg. Med. 3 1996 109 127
42. J.L. Wilson, L.E. Pettigrew, and G.M. Teasdale Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use J. Neurotrauma 15 1998 573 585
43. J.C. Brooks, D.J. Strauss, R.M. Shavelle, and et al. Long-term disability and survival in traumatic brain injury: results from the National Institute on Disability and Rehabilitation research model systems Arch. Phys. Med. Rehabil. 94 2013 2203 2209
44. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
45. I. Roberts, D. Yates, P. Sandercock, and et al. Effect of intravenous corticosteroids on death within 14 days in 10,008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial Lancet 364 2004 1321 1328
46. K.E. Saatman, A.-C. Duhaime, R. Bullock, and et al. Classification of traumatic brain injury for targeted therapies J. Neurotrauma 25 2008 719 738
47. A. Büki, and J. Povlishock All roads lead to disconnection? - Traumatic axonal injury revisited Acta Neurochir. 148 2006 181 194
48. D. Stein, R. Geddes, and E. Sribnick Recent developments in clinical trials for the treatment of traumatic brain injury Handb. Clin. Neurol. 127 2014 433 451
49. N.R. Temkin, G.D. Anderson, H.R. Winn, and et al. Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial Lancet Neurol. 6 2007 29 38
50. G.T. Manley, and A.I. Maas Traumatic brain injury: an international knowledge-based approach JAMA 310 2013 473 474
51. R.K. Narayan, M.E. Michel, B. Ansell, and et al. Clinical trials in head injury J. Neurotrauma 19 2002 503 557
52. G.D. Anderson, F.M. Farin, T.K. Bammler, and et al. The effect of progesterone dose on gene expression after traumatic brain injury J. Neurotrauma 28 2011 1827 1843
53. R.L. Roof, R. Duvdevani, and D.G. Stein Progesterone treatment attenuates brain edema following contusion injury in male and female rats Restor. Neurol. Neurosci. 4 1992 425 427
54. S. Smith Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells Neuroscience 42 1991 309 320
55. B.J. Blyth, A. Farhavar, C. Gee, and et al. Validation of serum markers for blood-brain barrier disruption in traumatic brain injury J. Neurotrauma 26 2009 1497 1507
56. D.G. Stein Progesterone exerts neuroprotective effects after brain injury Brain Res. Rev. 57 2008 386 397
57. D.D. Clarke, and L. Sokoloff Circulation and energy metabolism of the brain Basic Neurochem. Mol. Cell. Med. Asp. 6 1999 637 669
58. A. Paolin, L. Nardin, P. Gaetani, and et al. Oxidative damage after severe head injury and its relationship to neurological outcome Neurosurgery 51 2002 949 954 discussion 954-945
59. I. Solaroglu, O. Okutan, E. Kaptanoglu, and et al. Increased xanthine oxidase activity after traumatic brain injury in rats J. Clin. Neurosci. 12 2005 273 275
60. P.G. Sullivan, J.N. Keller, M.P. Mattson, and S.W. Scheff Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function J. Neurotrauma 15 1998 789 798
61. M. Herrmann, and H. Ehrenreich Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring Restor. Neurol. Neurosci. 22 2004 57
62. A. Kleindienst, F. Hesse, M.R. Bullock, and M. Buchfelder The neurotrophic protein S100B: value as a marker of brain damage and possible therapeutic implications Prog. Brain Res. 161 2007 317 325
63. G. Chen, J.X. Shi, M. Qi, and et al. Effects of progesterone on intestinal inflammatory response, mucosa structure alterations, and apoptosis following traumatic brain injury in male rats J. Surg. Res. 147 2008 92 98
64. C.L. Gibson, D. Constantin, M.J. Prior, and et al. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia Exp. Neurol. 193 2005 522 530
65. A. Helmy, K.L. Carpenter, J.N. Skepper, and et al. Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery J. Neurotrauma 26 2009 549 561
66. K.-T. Lu, C.-Y. Wu, H.-H. Yen, and et al. Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression Neurol. Res. 29 2007 404 409
67. M. Khaksari, Z. Keshavarzi, A. Gholamhoseinian, and B. Bibak The effect of female sexual hormones on the intestinal and serum cytokine response after traumatic brain injury: different roles for estrogen receptor subtypes Can. J. Physiol. Pharmacol. 91 2013 700 707
68. A. Lenz, G.A. Franklin, and W.G. Cheadle Systemic inflammation after trauma Injury 38 2007 1336 1345
69. B.E. Barton, and J.V. Jackson Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model Infect. Immun. 61 1993 1496 1499
70. A. Chiaretti, A. Antonelli, R. Riccardi, and et al. Nerve growth factor expression correlates with severity and outcome of traumatic brain injury in children Eur. J. Paediatr. Neurol. 12 2008 195 204
71. S.M. Beni, R. Kohen, R.J. Reiter, and et al. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-κB and AP-1 FASEB J. 18 2004 149 151
72. J.H. Heo, S.W. Han, and S.K. Lee Free radicals as triggers of brain edema formation after stroke Free Radic. Biol. Med. 39 2005 51 70
73. P.M. Kochanek, R.P. Berger, H. Bayr, and et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanisms, and therapeutic decision making Curr. Opin. Crit. Care 14 2008 135 141